Connect with us

News

COVID-19: Nigeria vaccinates 440,000 health workers – NPHCDA

Published




 

Dr Faisal Shuaib, the Executive Director, National Primary Health Care Development Agency (NPHCDA), on Tuesday, said no fewer than 440,000 healthcare workers have received their first dose of the Oxford-AstraZeneca COVID-19 vaccines in the country.

Shuaib said the 440,000 health workers represented 23 per cent of people that had received first the shot of the COVID-19 vaccine.

The NPHCDA boss also stated that 1,929,237 Nigerians representing 96 percent of the targeted population had so far been vaccinated against the virus, which had claimed over 3 million lives globally and over 2,000 lives in the country.

According to Shuaib, administering the second dose of the vaccine has begun and over 4,000 people have received theirs.

“Those individuals currently eligible for second dose will have received their first dose 6 to 12 weeks ago,” he said during a media briefing.

He urged all Nigerians to receive their second dose of the vaccine to gain full protection against the virus.

MORE READING!  Australian man falls to death from hot-air balloon

He added that this would enable the country to achieve herd immunity against COVID-19, noting that the country had set an ambitious goal of vaccinating 40 per cent of its over 200 million population before the end of 2021, and 70 per cent by the end of 2022.

Meanwhile, Shuaib said the global community was facing great challenges regarding vaccine supply, adding that like most nations, this impacts the clarity over Nigeria’s next shipment.

“While we have information that we may get the next consignment of vaccines by end of July or August, this has not been officially confirmed.

“When we are able to, we will provide an update regarding timelines and details of the next shipment.

“At present, we do not have that information available due to the wider context we are in,” he said.

MORE READING!  Data protection commission probe into NIMC privacy breach

He, however, said Pfizer and BioNTech pledged last week to provide one billion doses of their COVID-19 vaccines to low-and-middle-income countries by the end of 2021, and another one billion doses in 2022.

“Johnson & Johnson also announced it has signed a deal to provide 200 million doses of its vaccine to COVAX,” he explained.

According to him, the International Monetary Fund (IMF) is now advocating for a $50bn fund to be spent on ensuring a faster rollout of COVID-19 vaccines globally.

He said the IMF also called for at least 40 per cent of the global population to be vaccinated by the end of this year, and 60 per cent by June 2022.

He noted that the money would be used to increase COVAX vaccine coverage, procure additional tests and expand vaccine production capacity.

MORE READING!  Senate demands justice for slain army personnel in Delta

“We strongly endorse the creation of such a fund, and emphasise that all nations must have comparable access to COVID-19 vaccines in order to end this pandemic.

“Additionally, the United States announced it will donate 20 million vaccine doses by the end of June to the COVAX scheme,” he added.

Speaking at the briefing, a representative of the United Nation’s Children Fund (UNICEF) in Nigeria, Dr Peter Hawkins, said there were ongoing efforts to get vaccines to hard to reach areas in the country.

“Nobody is safe until everybody is vaccinated. We can not underestimate the steps taken and the challenges ahead,” Mr Hawkins said.

He also urged governors, traditional and other leaders to encourage their people to come out and be vaccinated for the safety of all.

NAN

Advertisement
Comments



Trending